These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 28965741)

  • 21. Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit.
    Finkelsztein EJ; Jones DS; Ma KC; Pabón MA; Delgado T; Nakahira K; Arbo JE; Berlin DA; Schenck EJ; Choi AM; Siempos II
    Crit Care; 2017 Mar; 21(1):73. PubMed ID: 28342442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers predicting sepsis in polytrauma patients: Current evidence.
    Ciriello V; Gudipati S; Stavrou PZ; Kanakaris NK; Bellamy MC; Giannoudis PV
    Injury; 2013 Dec; 44(12):1680-92. PubMed ID: 24119650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of Procalcitonin as a Biomarker for Sepsis in Children.
    Downes KJ; Fitzgerald JC; Weiss SL
    J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32350044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients.
    Hsu KH; Chan MC; Wang JM; Lin LY; Wu CL
    Respirology; 2011 Jan; 16(1):152-60. PubMed ID: 20946336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical diagnosis of sepsis and the combined use of biomarkers and culture- and non-culture-based assays.
    Bloos F
    Methods Mol Biol; 2015; 1237():247-60. PubMed ID: 25319792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
    Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
    Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.
    Póvoa P; Coelho L; Dal-Pizzol F; Ferrer R; Huttner A; Conway Morris A; Nobre V; Ramirez P; Rouze A; Salluh J; Singer M; Sweeney DA; Torres A; Waterer G; Kalil AC
    Intensive Care Med; 2023 Feb; 49(2):142-153. PubMed ID: 36592205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of presepsin for the evaluation of sepsis in the emergency department.
    Pizzolato E; Ulla M; Galluzzo C; Lucchiari M; Manetta T; Lupia E; Mengozzi G; Battista S
    Clin Chem Lab Med; 2014 Oct; 52(10):1395-400. PubMed ID: 24897403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers in the critically ill patient: procalcitonin.
    Reinhart K; Meisner M
    Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the value of dynamic procalcitonin and presepsin measurements for patients with severe sepsis.
    Yu H; Qi Z; Hang C; Fang Y; Shao R; Li C
    Am J Emerg Med; 2017 Jun; 35(6):835-841. PubMed ID: 28153679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
    Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
    Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil CD64 - A potential biomarker in patients with complicated intra-abdominal infections? - A literature review.
    Dimitrov E; Enchev E; Halacheva K; Minkov G; Yovtchev Y
    Acta Microbiol Immunol Hung; 2018 Aug; 65(3):245-254. PubMed ID: 29471687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sepsis and identification of reliable biomarkers for postoperative period prognosis.
    Siloşi CA; Siloşi I; Pădureanu V; Bogdan M; Mogoantă SŞ; Ciurea ME; Cojocaru M; Boldeanu L; Avrămescu CS; Boldeanu MV; Popa DG
    Rom J Morphol Embryol; 2018; 59(1):77-91. PubMed ID: 29940615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts.
    McHugh L; Seldon TA; Brandon RA; Kirk JT; Rapisarda A; Sutherland AJ; Presneill JJ; Venter DJ; Lipman J; Thomas MR; Klein Klouwenberg PM; van Vught L; Scicluna B; Bonten M; Cremer OL; Schultz MJ; van der Poll T; Yager TD; Brandon RB
    PLoS Med; 2015 Dec; 12(12):e1001916. PubMed ID: 26645559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sepsis biomarkers in neutropaenic systemic inflammatory response syndrome patients on standard care wards.
    Ratzinger F; Haslacher H; Perkmann T; Schmetterer KG; Poeppl W; Mitteregger D; Dorffner G; Burgmann H
    Eur J Clin Invest; 2015 Aug; 45(8):815-23. PubMed ID: 26046926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of procalcitonin in critically ill trauma patients.
    Sakran JV; Michetti CP; Sheridan MJ; Richmond R; Waked T; Aldaghlas T; Rizzo A; Griffen M; Fakhry SM
    J Trauma Acute Care Surg; 2012 Aug; 73(2):413-8; discussion 418. PubMed ID: 22846948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure].
    Galeano D; Zanoli L; Fatuzzo P; Granata A
    G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
    Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
    Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic inflammatory response syndrome criteria in defining severe sepsis.
    Kaukonen KM; Bailey M; Pilcher D; Cooper DJ; Bellomo R
    N Engl J Med; 2015 Apr; 372(17):1629-38. PubMed ID: 25776936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble Triggering Receptor Expressed on Myeloid Cells-1 as a Novel Marker for Abdominal Sepsis.
    Song X; Song Y; Zhang X; Xue H
    Surg Infect (Larchmt); 2017 Jul; 18(5):577-581. PubMed ID: 28266902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.